We next evaluated protein expression profiles using data from the Clinical Proteomic Tumor Analysis Consortium, which confirmed elevated RIPK1, RIPK3, and MLKL protein abundance in GBM relative to normal tissue (Fig. S1C). Here, RIPK1 is linked to glioblastoma.